Secondary analysis of the ERSPC prostate cancer screening trial (men aged 55–69): across three screening rounds, low-grade cancer detection exceeded intermediate- and high-grade, while high-grade detection trends varied substantially between centres.
Secondary analysis
Pasanen et al. Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC)